Aeterna Zentaris

A speciality biopharmaceutical firm focused on areas of significant unmet medical need that is developing and commercialising a diverse portfolio of pharmacological and diagnostic products. The company’s flagship product, macimorelin, is the first and only oral test for adult growth hormone insufficiency to be approved by the U.S. Food and Drug Administration and the European Commission (AGHD).